PMID- 37270256
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20230603
IS  - 1879-355X (Electronic)
IS  - 0360-3016 (Linking)
VI  - 116
IP  - 3
DP  - 2023 Jul 1
TI  - Erratum to: Randomized, Double-Blinded, Placebo-controlled Multicenter Adaptive 
      Phase 1-2 Trial of GC 4419, a Dismutase Mimetic, in Combination with High Dose 
      Stereotactic Body Radiation Therapy (SBRT) in Locally Advanced Pancreatic Cancer 
      (PC)  Int J Radiat Oncol Biol Phys 2020;108:1399-1400.
PG  - 698
LID - S0360-3016(23)00073-1 [pii]
LID - 10.1016/j.ijrobp.2023.01.025 [doi]
LA  - eng
PT  - Published Erratum
PL  - United States
TA  - Int J Radiat Oncol Biol Phys
JT  - International journal of radiation oncology, biology, physics
JID - 7603616
SB  - IM
EFR - Int J Radiat Oncol Biol Phys. 2020 Dec 1;108(5):1399-1400. PMID: 33427657
EDAT- 2023/06/04 01:08
MHDA- 2023/06/04 01:09
CRDT- 2023/06/03 21:01
PHST- 2023/06/04 01:09 [medline]
PHST- 2023/06/04 01:08 [pubmed]
PHST- 2023/06/03 21:01 [entrez]
AID - S0360-3016(23)00073-1 [pii]
AID - 10.1016/j.ijrobp.2023.01.025 [doi]
PST - ppublish
SO  - Int J Radiat Oncol Biol Phys. 2023 Jul 1;116(3):698. doi: 
      10.1016/j.ijrobp.2023.01.025.